Day: January 9, 2022

In the Era of the Boom of the Property Management Industry, Desun Services Adopts a Differentiated Approach

CHENGDU, China, Jan. 10, 2022 /PRNewswire/ — Nowadays, property developers are taking on unprecedented challenges. Under the multiple control measures such as the Three Red Lines policy and centralized land supply, the development of property developers is once again put on hold, leaving the capital markets fraught with pessimism about the property development industry. But surprisingly, the capital markets are […]

GSK Singapore announces availability of Shingrix in Singapore for shingles prevention

SINGAPORE, Jan. 10, 2022 /PRNewswire/ — GlaxoSmithKline (GSK) Singapore announced that a new vaccine to help protect against shingles, Shingrix, is now available in Singapore. Shingrix is a non-live, recombinant subunit adjuvanted vaccine, given intramuscularly in two doses, for the prevention of shingles (herpes zoster). The vaccine was initially approved for adults aged 50 years and over, […]

Baltic Exchange and TradeFlow Capital Management complete pioneering escrow transaction for a commodity export trade

SINGAPORE, Jan. 9, 2022 /PRNewswire/ — As the result of a partnership between the fintech-enabled fund manager TradeFlow Capital Management (TradeFlow), part of the Supply@Me Group (LON:SYME), and the Baltic Exchange, a leading provider of global freight market information and other maritime services, TradeFlow and the Baltic Exchange have successfully completed a pilot escrow transaction as […]

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

TIANJIN, China, Jan. 9, 2022 /PRNewswire/ — CanSino Biologics Inc. (“CanSinoBIO”) (SSE: 688185, HKEX: 06185) announced that the National Medical Products Administration of China (“NMPA”) granted approval for its ACYW135 Meningococcal Conjugate Vaccine (CRM197) (“MCV4”, trade name: Menhycia™), making it the first of its kind to be authorized in China. Leveraging CanSinoBIO’s industry-leading synthetic biotechnology […]

Back To Top